Traws Pharma (TRAW) EBITDA Margin (QoQ) (2012 - 2025)
Traws Pharma (TRAW) EBITDA Margin (QoQ) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.00 Bn | 132.14 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.24 Bn | 60.06 Bn | 1.37 Bn |
| 4 | Moderna | 62.41 Bn | 57.27 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.18 Bn | 27.88 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.93 Bn | 10.54 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - |
| 10 | Traws Pharma | 5.54 Mn | 527,765.92 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 908,237.00 |
| Mar 31, 2025 | 29,693.00 |
| Dec 31, 2024 | 555,044.00 |
| Sep 30, 2024 | 20.14 Mn |
| Jun 30, 2024 | -20.71 Mn |
| Mar 31, 2024 | -133,929.00 |
| Dec 31, 2023 | 96,021.00 |
| Sep 30, 2023 | -84,035.00 |
| Jun 30, 2023 | 287,121.00 |
| Mar 31, 2023 | -71,964.00 |
| Dec 31, 2022 | -34,279.00 |
| Sep 30, 2022 | -266,842.00 |
| Jun 30, 2022 | 15,050.00 |
| Mar 31, 2022 | -65,893.00 |
| Dec 31, 2021 | 28,036.00 |
| Sep 30, 2021 | 114,912.00 |
| Jun 30, 2021 | -83,127.00 |
| Mar 31, 2021 | 365,583.00 |
| Dec 31, 2020 | -146,762.00 |
| Sep 30, 2020 | 359,930.00 |